From: Overnight orthokeratology is comparable with atropine in controlling myopia
 | OK#(mean ± SD) | Atropine$(mean ± SD) | pvalue |
---|---|---|---|
Age, y/o | 11.82 ± 1.25 | 11.12 ± 1.68 | 0.745 |
Sex, M/F | 1: 0.99 | 1: 098 | 0.987 |
Myopia (Dd) | 1.5 to 7.5 (4.25 ± 1.5) | 1.5 to 7.5 (4.0 ± 1.75) | 0.975 |
Astigmatism (D) | 0 to 2.75 (0.75 ± 0.75) | 0 to 2.75 (0.5D ± 0.75) | 0.897 |
UCVA* (log MARb) | 0.8 ± 0.45 | 0.81 ± 0.28 | 0.982 |
BCVAa (log MAR) | 0.1 ± 0.015 | 0.12 ± 0.05 | 0.876 |
Axial length (mm) | 24.12 ± 1.25 | 24.23 ± 1.35 | 0.985 |